Skip to main content
    Health Library

    Weight management · 4 min read · Evidence-informed guide

    Oral Wegovy and Oral Semaglutide: What to Know

    Wegovy is available as an FDA-approved injectable and an FDA-approved oral semaglutide tablet for chronic weight management in qualifying adults. Oral semaglutide products are not interchangeable by name or dose; use only the formulation, dose, and indication prescribed for you.

    Key answer

    The short version

    Wegovy is available as an FDA-approved injectable and an FDA-approved oral semaglutide tablet for chronic weight management in qualifying adults. Oral semaglutide products are not interchangeable by name or dose; use only the formulation, dose, and indication prescribed for you.

    Route changes the treatment plan

    Wegovy tablets are taken orally once daily according to their prescribing information, while Wegovy injection is administered once weekly. The label includes distinct titration schedules, administration instructions, and dose strengths.

    Do not substitute products yourself

    Rybelsus, Ozempic, and Wegovy are semaglutide products with different FDA-approved uses and dosing. Do not combine semaglutide-containing products or switch formulations without the prescriber’s direction.

    Safety review still applies

    The oral formulation carries important warnings, contraindications, pregnancy guidance, and interaction considerations. A medication visit should review the complete label and your individual medical history.

    Clinical perspective

    How to think about this

    Prescription weight management is longitudinal medical care, not a consumer transaction. A sound plan weighs approved use, safety, nutrition, access, follow-up, and the patient’s own goals; it should never reduce a complex health decision to a promised outcome or a single number on a scale.

    Questions worth bringing to a visit

    • What FDA-approved option, if any, fits my clinical situation?
    • What safety monitoring and follow-up would I need?
    • How will we assess benefit, tolerability, and access over time?

    Continue exploring

    Related patient questions

    GLP-1 Weight-Loss Medicines: Questions to AskRead article Semaglutide vs. Tirzepatide: What Is the Difference?Read article Who May Qualify for GLP-1 Weight-Loss Medicine?Read article

    Sources

    1. 1. FDA, Wegovy Prescribing Information

      Current oral and injectable Wegovy indications, dosing, and warnings.

    2. 2. FDA, Wegovy oral-tablet regulatory review

      FDA review describing oral semaglutide formulation and indication.